 | • レポートコード：QYR2104Z3961 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、マルチプレックス診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500プレックス～プレックス10,000以下）、中密度マルチプレックスアッセイ（プレックス500以下）、低密度マルチプレックスアッセイ（プレックス5以下）、次世代シーケンシングアッセイ）、用途別市場規模（学術研究所、病院、製薬会社、臨床研究機関、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・マルチプレックス診断の市場動向 ・企業の競争状況、市場シェア ・マルチプレックス診断の種類別市場規模（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500プレックス～プレックス10,000以下）、中密度マルチプレックスアッセイ（プレックス500以下）、低密度マルチプレックスアッセイ（プレックス5以下）、次世代シーケンシングアッセイ） ・マルチプレックス診断の用途別市場規模（学術研究所、病院、製薬会社、臨床研究機関、診断研究所） ・マルチプレックス診断の北米市場規模2016-2027（アメリカ、カナダ） ・マルチプレックス診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・マルチプレックス診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・マルチプレックス診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・マルチプレックス診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent Technologies、Bio-Rad Laboratories, Inc.、BioMerieux SA、F. Hoffmann-La Roche Ltd.、Illumina, Inc.、Luminex Corporation、Hologic, Inc.、Thermo Fisher Scientific, Inc.、Siemens Healthineers、Abbott Laboratories） ・結論 |
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Market Analysis and Insights: Global Multiplexed Diagnostics Market
The global Multiplexed Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiplexed Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiplexed Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiplexed Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiplexed Diagnostics market.
Global Multiplexed Diagnostics Scope and Market Size
Multiplexed Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiplexed Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Segment by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agilent Technologies
Bio-Rad Laboratories, Inc.
BioMerieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Luminex Corporation
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthineers
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.2.4 Medium Density Multiplexed Assays (plex Below 500)
1.2.5 Low Density Multiplexed Assays (plex Below 5)
1.2.6 Next Generation Sequencing Assays
1.3 Market by Application
1.3.1 Global Multiplexed Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2016-2027)
2.2 Multiplexed Diagnostics Growth Trends by Regions
2.2.1 Multiplexed Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiplexed Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Multiplexed Diagnostics Industry Dynamic
2.3.1 Multiplexed Diagnostics Market Trends
2.3.2 Multiplexed Diagnostics Market Drivers
2.3.3 Multiplexed Diagnostics Market Challenges
2.3.4 Multiplexed Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Revenue
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
3.4 Global Multiplexed Diagnostics Market Concentration Ratio
3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2020
3.5 Multiplexed Diagnostics Key Players Head office and Area Served
3.6 Key Players Multiplexed Diagnostics Product Solution and Service
3.7 Date of Enter into Multiplexed Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplexed Diagnostics Breakdown Data by Type
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2022-2027)
5 Multiplexed Diagnostics Breakdown Data by Application
5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2016-2027)
6.2 North America Multiplexed Diagnostics Market Size by Type
6.2.1 North America Multiplexed Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Multiplexed Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Multiplexed Diagnostics Market Size by Type (2016-2027)
6.3 North America Multiplexed Diagnostics Market Size by Application
6.3.1 North America Multiplexed Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Multiplexed Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Multiplexed Diagnostics Market Size by Application (2016-2027)
6.4 North America Multiplexed Diagnostics Market Size by Country
6.4.1 North America Multiplexed Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Multiplexed Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2016-2027)
7.2 Europe Multiplexed Diagnostics Market Size by Type
7.2.1 Europe Multiplexed Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Multiplexed Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Multiplexed Diagnostics Market Size by Type (2016-2027)
7.3 Europe Multiplexed Diagnostics Market Size by Application
7.3.1 Europe Multiplexed Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Multiplexed Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Multiplexed Diagnostics Market Size by Application (2016-2027)
7.4 Europe Multiplexed Diagnostics Market Size by Country
7.4.1 Europe Multiplexed Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Multiplexed Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Multiplexed Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Multiplexed Diagnostics Market Size by Type
8.2.1 Asia-Pacific Multiplexed Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiplexed Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiplexed Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiplexed Diagnostics Market Size by Application
8.3.1 Asia-Pacific Multiplexed Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiplexed Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiplexed Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiplexed Diagnostics Market Size by Region
8.4.1 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Multiplexed Diagnostics Market Size (2016-2027)
9.2 Latin America Multiplexed Diagnostics Market Size by Type
9.2.1 Latin America Multiplexed Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Multiplexed Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Multiplexed Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Multiplexed Diagnostics Market Size by Application
9.3.1 Latin America Multiplexed Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Multiplexed Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Multiplexed Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Multiplexed Diagnostics Market Size by Country
9.4.1 Latin America Multiplexed Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Multiplexed Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplexed Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Multiplexed Diagnostics Market Size by Type
10.2.1 Middle East & Africa Multiplexed Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiplexed Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiplexed Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiplexed Diagnostics Market Size by Application
10.3.1 Middle East & Africa Multiplexed Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiplexed Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiplexed Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiplexed Diagnostics Market Size by Country
10.4.1 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 BioMerieux SA
11.3.1 BioMerieux SA Company Details
11.3.2 BioMerieux SA Business Overview
11.3.3 BioMerieux SA Multiplexed Diagnostics Introduction
11.3.4 BioMerieux SA Revenue in Multiplexed Diagnostics Business (2016-2021)
11.3.5 BioMerieux SA Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Details
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Details
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Multiplexed Diagnostics Introduction
11.5.4 Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021)
11.5.5 Illumina, Inc. Recent Development
11.6 Luminex Corporation
11.6.1 Luminex Corporation Company Details
11.6.2 Luminex Corporation Business Overview
11.6.3 Luminex Corporation Multiplexed Diagnostics Introduction
11.6.4 Luminex Corporation Revenue in Multiplexed Diagnostics Business (2016-2021)
11.6.5 Luminex Corporation Recent Development
11.7 Hologic, Inc.
11.7.1 Hologic, Inc. Company Details
11.7.2 Hologic, Inc. Business Overview
11.7.3 Hologic, Inc. Multiplexed Diagnostics Introduction
11.7.4 Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021)
11.7.5 Hologic, Inc. Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Details
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
11.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2016-2021)
11.9.5 Siemens Healthineers Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
11.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2016-2021)
11.10.5 Abbott Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Multiplexed Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Very High Density Multiplexed Assays (Above 10,000-plex)
Table 3. Key Players of High Density Multiplexed Assays (500 Below plex Below 10,000)
Table 4. Key Players of Medium Density Multiplexed Assays (plex Below 500)
Table 5. Key Players of Low Density Multiplexed Assays (plex Below 5)
Table 6. Key Players of Next Generation Sequencing Assays
Table 7. Global Multiplexed Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Multiplexed Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Multiplexed Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Multiplexed Diagnostics Market Share by Regions (2016-2021)
Table 11. Global Multiplexed Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Multiplexed Diagnostics Market Share by Regions (2022-2027)
Table 13. Multiplexed Diagnostics Market Trends
Table 14. Multiplexed Diagnostics Market Drivers
Table 15. Multiplexed Diagnostics Market Challenges
Table 16. Multiplexed Diagnostics Market Restraints
Table 17. Global Multiplexed Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Multiplexed Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiplexed Diagnostics as of 2020)
Table 20. Ranking of Global Top Multiplexed Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Multiplexed Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiplexed Diagnostics Product Solution and Service
Table 24. Date of Enter into Multiplexed Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Multiplexed Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global Multiplexed Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Multiplexed Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Multiplexed Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Multiplexed Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global Multiplexed Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Multiplexed Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Multiplexed Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Multiplexed Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Multiplexed Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Multiplexed Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Multiplexed Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Multiplexed Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Multiplexed Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Multiplexed Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Multiplexed Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Multiplexed Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiplexed Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiplexed Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Multiplexed Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Multiplexed Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Multiplexed Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Multiplexed Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Multiplexed Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Multiplexed Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Multiplexed Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiplexed Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiplexed Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiplexed Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Multiplexed Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Multiplexed Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Agilent Technologies Company Details
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies Multiplexed Diagnostics Product
Table 67. Agilent Technologies Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Agilent Technologies Recent Development
Table 69. Bio-Rad Laboratories, Inc. Company Details
Table 70. Bio-Rad Laboratories, Inc. Business Overview
Table 71. Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Product
Table 72. Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Bio-Rad Laboratories, Inc. Recent Development
Table 74. BioMerieux SA Company Details
Table 75. BioMerieux SA Business Overview
Table 76. BioMerieux SA Multiplexed Diagnostics Product
Table 77. BioMerieux SA Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 78. BioMerieux SA Recent Development
Table 79. F. Hoffmann-La Roche Ltd. Company Details
Table 80. F. Hoffmann-La Roche Ltd. Business Overview
Table 81. F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Product
Table 82. F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 83. F. Hoffmann-La Roche Ltd. Recent Development
Table 84. Illumina, Inc. Company Details
Table 85. Illumina, Inc. Business Overview
Table 86. Illumina, Inc. Multiplexed Diagnostics Product
Table 87. Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Illumina, Inc. Recent Development
Table 89. Luminex Corporation Company Details
Table 90. Luminex Corporation Business Overview
Table 91. Luminex Corporation Multiplexed Diagnostics Product
Table 92. Luminex Corporation Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 93. Luminex Corporation Recent Development
Table 94. Hologic, Inc. Company Details
Table 95. Hologic, Inc. Business Overview
Table 96. Hologic, Inc. Multiplexed Diagnostics Product
Table 97. Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 98. Hologic, Inc. Recent Development
Table 99. Thermo Fisher Scientific, Inc. Company Details
Table 100. Thermo Fisher Scientific, Inc. Business Overview
Table 101. Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Thermo Fisher Scientific, Inc. Recent Development
Table 103. Siemens Healthineers Company Details
Table 104. Siemens Healthineers Business Overview
Table 105. Siemens Healthineers Multiplexed Diagnostics Product
Table 106. Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 107. Siemens Healthineers Recent Development
Table 108. Abbott Laboratories Company Details
Table 109. Abbott Laboratories Business Overview
Table 110. Abbott Laboratories Multiplexed Diagnostics Product
Table 111. Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2016-2021) & (US$ Million)
Table 112. Abbott Laboratories Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplexed Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Very High Density Multiplexed Assays (Above 10,000-plex) Features
Figure 3. High Density Multiplexed Assays (500 Below plex Below 10,000) Features
Figure 4. Medium Density Multiplexed Assays (plex Below 500) Features
Figure 5. Low Density Multiplexed Assays (plex Below 5) Features
Figure 6. Next Generation Sequencing Assays Features
Figure 7. Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Academic Research Institutes Case Studies
Figure 9. Hospital Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Multiplexed Diagnostics Report Years Considered
Figure 14. Global Multiplexed Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Multiplexed Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Multiplexed Diagnostics Market Share by Regions: 2020 VS 2027
Figure 17. Global Multiplexed Diagnostics Market Share by Regions (2022-2027)
Figure 18. Global Multiplexed Diagnostics Market Share by Players in 2020
Figure 19. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiplexed Diagnostics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Multiplexed Diagnostics Revenue in 2020
Figure 21. Global Multiplexed Diagnostics Revenue Market Share by Type (2016-2021)
Figure 22. Global Multiplexed Diagnostics Revenue Market Share by Type (2022-2027)
Figure 23. North America Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Multiplexed Diagnostics Market Share by Type (2016-2027)
Figure 25. North America Multiplexed Diagnostics Market Share by Application (2016-2027)
Figure 26. North America Multiplexed Diagnostics Market Share by Country (2016-2027)
Figure 27. United States Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Multiplexed Diagnostics Market Share by Type (2016-2027)
Figure 31. Europe Multiplexed Diagnostics Market Share by Application (2016-2027)
Figure 32. Europe Multiplexed Diagnostics Market Share by Country (2016-2027)
Figure 33. Germany Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Multiplexed Diagnostics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Multiplexed Diagnostics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Multiplexed Diagnostics Market Share by Region (2016-2027)
Figure 43. China Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Multiplexed Diagnostics Market Share by Type (2016-2027)
Figure 51. Latin America Multiplexed Diagnostics Market Share by Application (2016-2027)
Figure 52. Latin America Multiplexed Diagnostics Market Share by Country (2016-2027)
Figure 53. Mexico Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Multiplexed Diagnostics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Multiplexed Diagnostics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Multiplexed Diagnostics Market Share by Country (2016-2027)
Figure 59. Turkey Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Multiplexed Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Agilent Technologies Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 63. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 64. BioMerieux SA Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 66. Illumina, Inc. Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 67. Luminex Corporation Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 68. Hologic, Inc. Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 69. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 70. Siemens Healthineers Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 71. Abbott Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の高密度マルチプレックス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-density Multiplexed Diagnostic Assays Market The global High-density Multiplexed Diagnostic Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…- 世界の高密度マルチプレックス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-density Multiplexed Diagnostic Assays Market The global High-density Multiplexed Diagnostic Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…
- 世界の高密度マルチプレックス診断検査市場 2021：企業別、地域別、種類・用途別 The High-density Multiplexed Diagnostic Assays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の免疫蛍光アッセイ市場規模・現状・予測（2021年-2027年） Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcof…
- 世界のマルチプレックスPCRアッセイ市場規模・現状・予測（2021年-2027年） Multiplex PCR, also known as multiplex primer PCR or multiplex PCR, is a PCR reaction in which more than two pairs of primers are added to the same PCR reaction system, and at the same time, multiple nucleic acid fragments are amplified The Reaction Reagent and the operation process are the same as …